Running Global Trials Without Losing Compliance: Key GCP and Regulatory Considerations
- 0:00 Why Global Compliance Slips
- 8:00 GCP Core Versus Local Rules
- 18:00 Country Start-Up Without Surprises
Practical shifts you can apply this week
-
Identify Compliance Pressure Points
Spot where multinational studies most often drift into findings across oversight, documentation, and timing.
-
Compare ICH-GCP Expectations
See how global standards meet local ethics and regulatory rules before a sound plan fails in-country.
-
Evaluate Audit Risk Decisions
Assess vendor, site, and data-flow choices with an inspection lens, not just an operations lens.
-
Design Country-Ready Oversight Plans
Build practical controls for safety, documentation, deviations, and handoffs across countries.
-
Decide Governance Actions Faster
Use a clear escalation path when local requirements conflict with global procedures. Fewer shrugs.
What we'll cover
-
0:00
Why Global Compliance Slips
A quick risk map of where cross-border trials go sideways and where inspectors usually start digging.
-
8:00
GCP Core Versus Local Rules
Compare ICH-GCP baselines with local law, ethics pathways, and what to do when requirements clash.
-
18:00
Country Start-Up Without Surprises
Avoid delays caused by sequencing, document ownership, translations, permits, indemnity, and insurance.
-
27:00
Vendor And CRO Oversight
Review accountability, oversight evidence, qualification triggers, KPIs, and documented escalations.
-
37:00
Data Privacy And Safety Reporting
Design cross-border data access and reporting timelines together so one fix does not break the other.
-
47:00
Sites And Inspection Readiness
Cover deviations, CAPA, training, consent, source credibility, and TMF habits that hold up under review.
-
56:00
Compliance Playbook And Q&A
Recap the framework, outline a 30-day gap review, and answer attendee questions.
Questions people ask before registering
-
It is built for working professionals involved in global clinical trials, including clinical operations, QA, regulatory, pharmacovigilance, and study oversight roles.
-
Some familiarity with trial operations helps, but you do not need deep regulatory expertise. The session starts with a practical risk map and builds from there.
-
If a replay is being offered by the host, attendees typically receive access after the session. Check your registration details for the exact replay policy.
-
It is designed as a practical training session. You will leave with a framework you can apply to an active or planned global study right away.
-
Certificate availability depends on the event host. If one is offered, the registration or follow-up email will usually explain how to receive it.
-
Yes. The session uses concrete cases, including consent translation delays, CRO oversight gaps, privacy remediation, and local safety reporting findings.